Hiroki Ozawa: New Guideline Updates on Pregnancy in Rheumatic Diseases
Hiroki Ozawa, Medical Doctor at St. Luke’s International Hospital, shared a post on LinkedIn:
“JCR 2026 Conference Report — Part 3 (Final): Pregnancy in RMD
Day 3 at JCR 2026 in Fukuoka brought an outstanding session on pregnancy complicated by rheumatic diseases. Here are the highlights.
Pregnancy in Rheumatic Diseases – Guideline Updates
This year saw the simultaneous revision of two Japanese clinical practice guidelines: one for anti-SS-A antibody-positive pregnancies and one for pregnancies complicated by antiphospholipid syndrome (APS). Naturally, the session was packed.
The session was chaired by Dr. Yokokawa, who has been doing critically important work – leading an investigator-initiated clinical trial on the use of hydroxychloroquine (HCQ) for the prevention of recurrent congenital heart block (CHB) in anti-SS-A antibody-positive pregnancies with a history of CHB in a prior child, and advocating for the expansion of HCQ’s approved indications to cover this use. CHB, though rare (approximately 1% of anti-SS-A-positive pregnancies), is irreversible and can be life-threatening, making prevention a top priority.
My colleagues Prof. Kishimoto, Dr. Kitada, and Dr. Nakai were also involved in the development of these guidelines – congratulations to them on this tremendous effort!
The anti-SS-A antibody-positive pregnancy guideline is structured around clinical questions (CQs) that follow the actual workflow of clinical care – from preconception assessment through postpartum follow-up of mother and child. This makes it highly practical and applicable at the bedside, bridging rheumatology, obstetrics, and pediatrics.
The APS pregnancy guideline is equally noteworthy for its inclusion of guidance on non-criteria APS – patients who are aPL-positive with pregnancy complications but do not fully meet formal classification criteria. This ensures that women who need treatment are not overlooked, reflecting a patient-centered approach to guideline development.
I look forward to the formal publication of both guidelines and to receiving feedback from colleagues around the world.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG